Maternal PAI-1 levels in the plasma are higher in patients with preeclampsia during the second trimester of pregnancy [67], and its mRNA levels are positively correlated with the severity of preeclampsia during 35–41 weeks of gestation [68]. Here, SERPINE1 is linked to preeclampsia.